Driven by a vision to liberate patients from the burden of degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicine that repairs the body when it cannot repair itself. Using an approach that can be applied to multiple disease areas with great unmet need, BlueRock is initially targeting severe cardiovascular and neurodegenerative diseases, with the goal of altering the course of disease and drastically improving quality of life. BlueRock and its team of preeminent scientists are pioneering cell therapies that replace dead, damaged or dysfunctional cells to restore critical natural functions in the body via induced pluripotent stem cells (iPSCs). The firm currently works in collaboration with leading academic and industrial partners, including Toronto's University Heath Network and the Memorial Sloan Kettering Cancer Center. BlueRock's culture is defined by scientific innovation, the highest ethical standards, and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Over the next 12 months, BlueRock will be significantly expanding staff at all locations. Please contact the company via LinkedIn or their corporate website to learn about rewarding career opportunities.

Legal name: BlueRock Therapeutics LP